Edesa Biotech, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Edesa Biotech, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Edesa Biotech, Inc. Return On Equity for the quarter ending June 30, 2024 was -138 %, a 33% decline year-over-year.
  • Edesa Biotech, Inc. annual Return On Equity for 2023 was -98 %, a 31.8% increase from 2022.
  • Edesa Biotech, Inc. annual Return On Equity for 2022 was -144 %, a 51% decline from 2021.
  • Edesa Biotech, Inc. annual Return On Equity for 2021 was -95.3 %, a 13.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -98 +45.8 +31.8% Oct 1, 2022 Sep 30, 2023
2022 -144 -48.6 -51% Oct 1, 2021 Sep 30, 2022
2021 -95.3 +14.7 +13.4% Oct 1, 2020 Sep 30, 2021
2020 -110 Oct 1, 2019 Sep 30, 2020
2018 -25.7 +29.2 +53.1% Jan 1, 2018 Dec 31, 2018
2017 -54.9 -2.57 -4.91% Oct 1, 2016 Sep 30, 2017
2016 -52.3 -20.4 -63.8% Oct 1, 2015 Sep 30, 2016
2015 -32 Oct 1, 2014 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.